$0.10 $0.00 (-1.0%)

10:38 AM EST on 01/17/20

Elite Pharmaceuticals Inc (NASDAQOTH:ELTP)

CAPS Rating: No stars

A pharmaceutical company engaged in the development and manufacture of oral, controlled release products. It develops controlled release products using proprietary technology and licenses these products.

Current Price $0.10 Mkt Cap $85.3M
Open $0.10 P/E Ratio 0.00
Prev. Close $0.10 Div. (Yield) $0.00 (0.0%)
Daily Range $0.10 - $0.10 Volume 220,815
52-Wk Range $0.09 - $0.12 Avg. Daily Vol. 1,199,808

Caps

This ticker is not currently Ratable.

Add Stock to CAPS Watchlist

All Players

2 Outperform
0 Underperform
 

All-Star Players

0 Outperform
0 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQOTH:ELTP Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

Top Bull Pitch

There are no pitches that meet the Top Bull criteria. Explain

If this upsets you, start recommending pitches below!

Top Bear Pitch

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches below!

NASDAQOTH:ELTP VS S&P 500 (SPY)

Fools bullish on NASDAQOTH:ELTP are also bullish on:

Recent Community Commentary

Read the most recent pitches from players about ELTP.

No one has written a Pitch for ELTP stock yet. Tell us why you think ELTP will outperform or underperform against the market.

Leaderboard

Find the members with the highest scoring picks in ELTP.

Score Leader

JoeySolitro1

JoeySolitro1 (99.99) Score: +97.66

The Score Leader is the player with the highest score across all their picks in ELTP.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
ABLAST < 20 2/26/2014 Outperform 5Y $0.60 -83.33% +79.09% -162.43 0 Comment
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. Fishymoon < 20 3/4/2014 Outperform 3Y $0.76 -86.86% +77.52% -164.38 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for ELTP.